BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 18801622)

  • 41. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Psychiatric symptoms in Cushing syndrome: a clinical case].
    Cañas Cañas MT; Ruiz Sanz E; Gil-Díaz Usandizaga C; Sotelo E
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(6):395-8. PubMed ID: 9972592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melatonin secretion and non-specific immune responses are differentially expressed in corticotropin-dependent and corticotropin-independent Cushing's syndrome.
    Tomova A; Kumanov P; Robeva R; Manchev S; Konakchieva R
    Med Sci Monit; 2008 Jun; 14(6):CR327-332. PubMed ID: 18509277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cushing's Syndrome : an overview.
    Cincu C; Agrawal A
    JNMA J Nepal Med Assoc; 2006; 45(164):375-80. PubMed ID: 17676077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adipokines and cardiovascular risk in Cushing's syndrome.
    Valassi E; Biller BM; Klibanski A; Misra M
    Neuroendocrinology; 2012; 95(3):187-206. PubMed ID: 22057123
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclic Cushing syndrome: definitions and treatment implications.
    Velez DA; Mayberg MR; Ludlam WH
    Neurosurg Focus; 2007; 23(3):E4; discussion E4a. PubMed ID: 17961029
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exogenous Cushing's syndrome and glucocorticoid withdrawal.
    Hopkins RL; Leinung MC
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):371-84, ix. PubMed ID: 15850848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myelolipomatous adrenal masses causing Cushing's syndrome.
    Lamas C; López LM; Lozano E; Atienzar M; Ruiz-Mondéjar R; Alfaro JJ; Botella F
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):440-5. PubMed ID: 19373749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.
    Csernansky JG; Dong H; Fagan AM; Wang L; Xiong C; Holtzman DM; Morris JC
    Am J Psychiatry; 2006 Dec; 163(12):2164-9. PubMed ID: 17151169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Food-dependent Cushing's syndrome.
    Messidoro C; Elte JW; Castro Cabezas M; van Agteren M; Lacroix A; de Herder WW
    Neth J Med; 2009 May; 67(5):187-90. PubMed ID: 19581669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MECHANISMS IN ENDOCRINOLOGY: A sense of time of the glucocorticoid circadian clock: from the ontogeny to the diagnosis of Cushing's syndrome.
    Moreira AC; Antonini SR; de Castro M
    Eur J Endocrinol; 2018 Jul; 179(1):R1-R18. PubMed ID: 29661784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent cognitive impairment following surgical treatment of Cushing's syndrome.
    Forget H; Lacroix A; Cohen H
    Psychoneuroendocrinology; 2002 Apr; 27(3):367-83. PubMed ID: 11818172
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Telomeres, aging and Cushing's syndrome: are they related?].
    Aulinas A; Santos A; Valassi E; Mato E; Crespo I; Resmini E; Roig O; Bell O; Webb SM
    Endocrinol Nutr; 2013; 60(6):329-35. PubMed ID: 23218933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Cushing's syndrome].
    Guignat L; Bertagna X; Bertherat J
    Rev Prat; 2008 May; 58(9):957-65. PubMed ID: 18672661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MANAGEMENT OF ENDOCRINE DISEASE: Management of pregnant patients with Cushing's syndrome.
    Bronstein MD; Machado MC; Fragoso MC
    Eur J Endocrinol; 2015 Aug; 173(2):R85-91. PubMed ID: 25872515
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is metabolic syndrome a mild form of Cushing's syndrome?
    Krikorian A; Khan M
    Rev Endocr Metab Disord; 2010 Jun; 11(2):141-5. PubMed ID: 20711679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia?
    Panza F; Capurso C; D'Introno A; Colacicco AM; Gadaleta A; Frisardi V; Santamato A; Capurso A; Solfrizzi V
    J Am Geriatr Soc; 2008 Jul; 56(7):1367-9. PubMed ID: 18774976
    [No Abstract]   [Full Text] [Related]  

  • 58. Cushing's syndrome.
    Hollfield JW
    J Tenn Med Assoc; 1977 Aug; 70(8):574-5. PubMed ID: 895130
    [No Abstract]   [Full Text] [Related]  

  • 59. Harmful effects of functional hypercortisolism: a working hypothesis.
    Tirabassi G; Boscaro M; Arnaldi G
    Endocrine; 2014 Aug; 46(3):370-86. PubMed ID: 24282037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Erratum to "CNS drugs in Cushing's disease: pathophysiological and therapeutic implications for mood disorders" [Prog. Neuro-Psycol. Biol. Psychiatry, 26, 763 (2002)].
    Sonino N; Fava GA
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jun; 26(5):1011-8. PubMed ID: 12369251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.